RUNNING POINT CAPITAL ADVISORS, LLC Intercept Pharmaceuticals, Inc. Transaction History

RUNNING POINT CAPITAL ADVISORS, LLC portfolio value:

$140,000
portfolio value

RUNNING POINT CAPITAL ADVISORS, LLC quarter portfolio value change:

+1.01%
quarter

Intercept Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 2K $13.95 10K
Q2 2022 share Decrease -0.11% -11 shares -25K $13.81 10K
Q1 2022 share Increase 0.00% 10.01K shares 163K $16.27 10.01K